Swamy Yeleswaram's most recent trade in Rapport Therapeutics Inc. was a trade of 110,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rapport Therapeutics Inc. | Swamy Yeleswaram | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 110,000 | 110,000 | - | - | Stock Option (Right to Buy) | |
| Rapport Therapeutics Inc. | Swamy Yeleswaram | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 84,904 | 84,904 | - | - | Stock Option (Right to Buy) |